Epigenetic modulator inhibition overcomes temozolomide chemoresistance and antagonizes tumor recurrence of glioblastoma

Glioblastoma multiforme (GBM) heterogeneity causes a greater number of deaths than any other brain tumor, despite the availability of alkylating chemotherapy. GBM stem-like cells (GSCs) contribute to GBM complexity and chemoresistance, but it remains challenging to identify and target GSCs or factor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Invest
Autors principals: Moon, Byoung-San, Cai, Mingyang, Lee, Grace, Zhao, Tong, Song, Xiaofeng, Giannotta, Steven L., Attenello, Frank J., Yu, Min, Lu, Wange
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7598052/
https://ncbi.nlm.nih.gov/pubmed/33016927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI127916
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars